Trim 30-35% of SBUX to 65-70% residual with $101.00-101.20 stop; maintain Underweight to preserve Japan-deal optionality pending Q4 FY26 catalyst
Trim 30-35% of existing SBUX long exposure (residual = 65-70% of normal Consumer Cyclical allocation), holding proceeds as dry powder. Adopt Underweight rating to preserve franchise-value optionality given potentially imminent Japan deal (Reuters confirms financial advisors engaged, PE interest real), rejecting full Sell that would destroy that upside. Maintain calibrated stop architecture at $101.00-101.20 on any short overlay — above the 10 EMA ($100.33) to avoid whipsaw trap. Bearish confirmation trigger: close below $97.20 on volume >12M targets $95.34 then $93.69. Q4 FY26 earnings (late October/early November) is the binary resolution window; upgrade to Hold if flat-to-positive organic comps (>3% US) with margin expansion, exit residual entirely if -1% or worse comps with flat-to-down margins. Current position is within Research Manager's 50-70% target band.
| Position | Action |
|---|---|
| Current setup (200 SMA pierced intraday but closed above) | Trim 30-35% of long exposure, targeting upper end of range |
| Short overlay sizing | 0.5-0.75% of portfolio per 9/15 calibration |
| Residual core position | Maintain 65-70% of normal Consumer Cyclical allocation |
SBUX at $97.34 represents a textbook asymmetric long at the 200 SMA after a hawkish Fed flush, with Q2 2026 fundamentals confirming the turnaround via margin expansion and deleveraging, supported by a 2.57% dividend yield and $5-7B buyback optionality—warranting a BUY rating at a 5:1 risk/reward.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 31.90 | bearish |
| MACD | -2.00 | bearish |
| MACD Signal | -0.96 | bearish |
| MACD Histogram | -1.04 | bearish |
| ATR | 2.44 | neutral |
| VWMA | $102.54 | bearish |
| Bollinger Upper Band | $111.51 | neutral |
| Bollinger Middle Band (20 SMA) | $103.77 | neutral |
| Bollinger Lower Band | $96.02 | neutral |
| 10 EMA | $100.33 | bearish |
| 50 SMA |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Close above $104.20 (50 SMA) on volume >6M
Then: Signal stabilization for partial add-back of trimmed position
Hawkish Fed is already priced in; SBUX's 2.57% dividend yield and fortress balance sheet make it a quality haven in hawkish regimes
↩ rebuts: “Bear Argument #2: Hawkish Fed hike! Multiple compression! 31x P/E!”
EV: +7.3%
The trend has flipped bearish across all technical indicators, the macro environment is actively hostile to high-multiple consumer discretionaries, and hidden fundamental weaknesses (underlying EPS ~$2.40-$2.80, negative book equity, sub-1 current ratio) make the risk/reward asymmetric to the downside with realistic downside targets of $93.69-$95.34.
· concedes: 200 SMA did hold as support, albeit by only $0.14; Japan sale does reduce net debt by $3.3B; SBUX dividend yield did exceed 10-year Treasury yields six months ago
→ vs conservative: Position sizing of 50-70% of normal Consumer Cyclical allocation doesn't go far enough—should be selling into the 200 SMA test, not merely reducing
→ vs neutral: 200 SMA defense is a technicality, not a defense—the intraday low of $96.08 means the 200 SMA has already been pierced; waiting for confirmed break is too late
→ vs conservative: 'Trap' pattern theory requires buyers with conviction, but 9.3M shares of volume on the decline shows conviction from sellers, not buyers
→ vs neutral: MACD, RSI, Bollinger all line up bearish simultaneously; closing $0.14 above a single moving average is noise in this context
→ vs conservative: Negative book equity of negative $7.67B and 0.76 current ratio are warning signs, not 'structural quirks'—company is levered with limited cushion
→ vs neutral: 31x forward P/E isn't 'reasonable'—it's the multiple of a stock that hasn't realized the new cost of capital in a hawkish regime
→ vs conservative: Japan sale is exploratory with no buyer, price, or close date; market pricing in $3B of capital that doesn't exist yet
→ vs neutral: Turnaround story is already priced in; underlying earnings power is $509M, not $1.05B—the gain rolls off next quarter
→ vs conservative: Being long highest-multiple consumer discretionary name in coverage during hawkish regime is low-probability bet; identifying headwind but refusing to act is dangerous analysis
| $104.49 |
| bearish |
| 200 SMA | $97.20 | neutral |
| Close | $97.34 | neutral |
| Today's Low | $96.08 | neutral |
| Today's High | $98.34 | neutral |
Support: 97.2 · 96.02 · 95.34 · 93.69 | Resistance: 100.33 · 102.01 · 102.8 · 104.49 · 107.49 · 108.49 · 111.51
The technical setup is strongly bearish with the 50 SMA and 10 EMA both lost, MACD confirming a bearish crossover with expanding negative histogram at –1.04, and RSI at 31.90 pressing toward oversold. Price is pressing the 200 SMA at $97.20 (holding by just $0.14 on the close) and the lower Bollinger band at $96.02 was tagged intraday. Key support lies at $97.20 (200 SMA), $96.02 (lower band), $95.34, and $93.69; resistance overhead sits at $100.33 (10 EMA), $104.49 (50 SMA), and $107.49–$108.49. Volume-weighted average price of $102.54 is well above current close, confirming sellers are in control on a volume-adjusted basis. The final transaction proposal is HOLD pending a decisive close below $97.20 (warranting SELL) or reclaim of $100 (tactical bounce setup).
Market Cap
$110.97B
PE Ratio (TTM)
56.27x
Forward PE
31.17x
PEG Ratio
1.18
Price to Book
-14.46x
Dividend Yield
2.57%
Beta
0.965
52-Week High
$110.51
52-Week Low
$77.99
50-Day Avg
$104.94
200-Day Avg
$98.10
Revenue (TTM)
$38.34B
Revenue Q2 2026
$9,323M
Gross Profit Q2 2026
$2,297M
Gross Margin Q2 2026
24.6%
Operating Income Q2 2026
$1,204M
Operating Margin Q2 2026
12.9%
Net Income Q2 2026
$1,045M
Diluted EPS Q2 2026
$0.91
EBITDA Q2 2026
$1,944M
Net Income (TTM)
$1.98B
Forward EPS Consensus
$3.12
TTM EPS
$1.73
EBITDA (TTM)
$5.64B
EBITDA Margin (TTM)
14.7%
Net Profit Margin (TTM)
5.17%
Total Assets Q2 2026
$28,295M
Total Liabilities Q2 2026
$35,962M
Stockholders' Equity Q2 2026
-$7,674M
Total Debt Q2 2026
$22,434M
Net Debt Q2 2026
$9,829M
Cash & Equivalents Q2 2026
$3,450M
Goodwill Q2 2026
$1,239M
Net PPE Q2 2026
$14,973M
Current Ratio Q2 2026
0.76
Operating Cash Flow Q2 2026
$1,642M
CapEx Q2 2026
-$291M
Free Cash Flow Q2 2026
$1,351M
Free Cash Flow (TTM)
$3.07B
Dividends Paid Q2 2026
-$707M
Debt Repaid Q2 2026
-$1,816M
Net Business Sale Q2 2026
$2,544M
Net Debt / EBITDA
~1.7x
Interest Coverage
~10x
ROA
8.02%
Annual Dividend Per Share
$2.48
Quarterly Dividend
$0.62/share
FCF Yield
~2.8%
52-Wk Position
~62% of range
Strengths
Concerns
Starbucks is a post-restructuring turnaround story at an attractive inflection point, having completed a major business divestiture in Q2 2026 that deployed $2.5B in proceeds toward debt reduction, cutting net debt from $13.15B to $9.83B. Q2 2026 demonstrated genuine margin expansion with gross margin up ~450bps QoQ to 24.6% and operating margin reaching 12.9%, though TTM metrics remain depressed by ~$1.6B in cumulative restructuring charges; the forward consensus of $3.12 EPS implies ~57% earnings recovery from the TTM base of $1.73. The stock warrants a HOLD rating—quality franchise in transition—awaiting cleaner Q3/Q4 2026 prints to confirm the earnings recovery before sizing aggressively, with the elevated forward P/E of 31x leaving limited margin for execution missteps.
Macro: Hawkish Fed surprise on Sept 16, 2026: central bank hiked policy rate (opposite of expected cuts), triggering sharp equity selloff. Polymarket pricing 95% probability of no Fed cuts in 2026 (vs. +1.9pp prior week). Rising yields create direct multiple-compression risk for premium-P/E Consumer Cyclical/Restaurant names like SBUX. US recession odds ticked up to 10% (+3pp) but remain low. Jamie Dimon reinforced hawkish tone. CLARITY Act failed in Senate, adding risk-off flows. SBUX down ~2.57% on session, already pricing in bearish macro backdrop.